Prialt FDA Approval History
FDA Approved: Yes (First approved December 28, 2004)
Brand name: Prialt
Generic name: ziconotide
Dosage form: Intrathecal Infusion
Company: Elan Corporation, plc
Treatment for: Pain
Prialt (ziconotide) is a non-opioid intrathecal (IT) therapy indicated for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or IT morphine.
Development timeline for Prialt
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.